Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by narmacon Dec 23, 2022 11:27am
105 Views
Post# 35189531

RE:Some Thoughts in Summary

RE:Some Thoughts in Summary,,Can this investment get any more erroded than it has ,,,it must be assumed it certainly can,,,,,it cant even be considered an investment anymore,,,,,it has been a divestment now since the topping out at $2 back in Sept/16. A time which was strike while the iron is hot!!,,What ever failure happened at that time is a big question for all investors!!!,,,a shame but yet rerality!

Now on life support at .05 cents it becomes at the most a tax loss instrument now or down the road.

I have little to no faith to even break even in the future. Since we will be owned and controlled by 3rd party entities,,,,,the management team in Biodexa become regular staff now,,,senior positions within are in effect,,, meaningless.
<< Previous
Bullboard Posts
Next >>